S 5059

A bill to amend the Public Health Service Act to streamline the review of biosimilar biological products.

Bill status

Status
In committee
Cosponsors
0
Latest action
2026-07-21: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.